26 Aug 2025Open access1cites
The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategiesPublisher siteMedical Oncology, Advanced Breast Cancer Therapies
Active, last published 2026
In nanoparticle-based drug delivery
Maha R. A.
Abdollah
Scholar“Research focused on Nanoparticle-Based Drug Delivery and adjacent fields.”
Claim Your Profile8
H-index
331
Citations
Maha has not officially claimed their profile. If you are Maha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aha R. A. Abdollah is a researcher working on Nanoparticle-Based Drug Delivery. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Maha's work has been cited 331 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Nanoparticle-Based Drug Delivery×4Cancer-related Molecular Pathways×3Metabolism, Diabetes, and Cancer×3Seaweed-derived Bioactive Compounds×3Characterization and Applications of Magnetic Nanoparticles×3
04 · Where I am
Affiliations
Affiliation on published researchBritish University in Egypt, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works25 Jul 20255cites
In vivo modulation of the tumor microenvironment: anti-tumor effects of combination therapy of fucoidan and small molecule immune checkpoint inhibitor BMS-202Publisher siteInternational Immunopharmacology, Seaweed-derived Bioactive Compounds
25 May 2025Open access
Corchorus olitorius exhibits antiproliferative potential supported by metabolic profiling and integrative biological analysesPublisher siteScientific Reports, Seed and Plant Biochemistry
1 Apr 2025Open access2cites
Trimetazidine mitigates methotrexate‐induced liver damage: Insights From biochemical, histological, and in silico analysesPublisher siteArchiv der Pharmazie, Acute Lymphoblastic Leukemia research
27 Mar 2025Open access2cites
Phytochemical Analysis and In Vivo Anticancer Effect of Becium grandiflorum: Isolation and Characterization of a Promising Cytotoxic DiterpenePublisher siteNutrients, Bioactive Natural Diterpenoids Research
1 Mar 20251cites
Evaluating Fucoidan as an Adjuvant Therapy to Clinically Approved Anti-Angiogenic Drugs: Insights from the Hen's Egg Test Chorioallantoic Membrane (HET-CAM) Assay (Abstract ID: 159250)Publisher siteJournal of Pharmacology and Experimental Therapeutics, Seaweed-derived Bioactive Compounds
1 Oct 2024Open access
Metformin and PRF enhaced the osteogenic differentiation of hPLSCsPublisher siteInternational Dental Journal, Metabolism, Diabetes, and Cancer
23 Oct 2023Open access11cites
Enhancing the anticancer potential of metformin: fabrication of efficient nanospanlastics, in vitro cytotoxic studies on HEP-2 cells and reactome enhanced pathway analysisPublisher siteInternational Journal of Pharmaceutics X, Metabolism, Diabetes, and Cancer
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Maha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you